[Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target]. / Colesterol ligado a lipoproteínas de baja densidad (LDL) y reducción del riesgo vascular. Proproteína convertasa subtilisina / kexina tipo 9 (PCSK9): una nueva diana terapéutica.
Med Clin (Barc)
; 145(2): 67-9, 2015 Jul 20.
Article
in Es
| MEDLINE
| ID: mdl-26004275
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Serine Endopeptidases
/
Proprotein Convertases
/
Hypercholesterolemia
/
Hyperlipoproteinemias
/
Lipoproteins, LDL
/
Antibodies, Monoclonal
/
Hypolipidemic Agents
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
Es
Journal:
Med Clin (Barc)
Year:
2015
Document type:
Article
Country of publication:
Spain